Connect with us

Hi, what are you looking for?

AIM Biotech Reviews Techniques to Improve T Cell Efficacy Using the Company’s Organ-on-a-Chip Technology (3D Cell Culture Plate)

Singapore & Boston, MA — July 26, 2021 –- AIM Biotech is providing an update on a technique using its organ-on-a-chip platform to further improve T cell efficacy. The Company’s 3D cell culture chips are being used in preclinical research to better understand Adoptive T Cell Immunotherapy, and, specifically, improve cancer treatment options with allogeneic (universal donor) engineered T Cells that could have fewer off target effective and greater capacity to kill cancer cells.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • AIM’s 3D cell culture chips are helping researchers bring about the next-generation of T-Cell therapies
  • A technique used by one research group revealed a certain type of engineered T-Cell had lower off-target effects and was more effective at killing cancer cells
  • This is another example of how AIM’s predictive platform is being used as a beneficial tool in cancer research to improve the probability of success

Click image above to view full announcement.

AIM gives researchers 3D human biology-on-a-chip to revolutionize their preclinical drug discovery and molecular research. At its core is the AIM Chip, a specialized 3D microfluidics device that makes it easy to generate relevant human data from disease-specific assays. Researchers are able to create their own assays or apply validated protocols, which include angiogenesis, vasculogenesis, metastasis, immuno-oncology, and 3D culture of tumor samples. AIM Biotech is located in Singapore and Boston, MA.


Media & Investors
[email protected]

Source: AIM Biotech

Distributed by: Reportable, Inc.

Written By

You may also like:

Tech & Science

 MusicLM is not the music box of the future. Ironically, it might just save music from people who should have nothing to do with...


A man counts US dollar banknotes in a Baghdad market on December 27, 2022 as the value of Iraqi dinar against US dollar drops...


The United States hit its borrowing cap of $31.4 trillion in January, prompting the start of measures to avoid a default.


Investors are keenly awaiting the Federal Reserve policy decision, hoping for clues about its plans for future interest rate hikes - Copyright AFP AHMAD...